Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Accenture
UBS
Daiichi Sankyo
Moodys
US Army
Johnson and Johnson
Cantor Fitzgerald

Generated: May 26, 2018

DrugPatentWatch Database Preview

IBUPROFEN SODIUM - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for ibuprofen sodium and what is the scope of ibuprofen sodium patent protection?

Ibuprofen sodium
is the generic ingredient in two branded drugs marketed by Pfizer Cons Hlthcare and Perrigo R And D, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-four drug master file entries for ibuprofen sodium. Seven suppliers are listed for this compound.
Synonyms for IBUPROFEN SODIUM
15687-27-1 (Parent)
2-(p-isobutylphenyl)propionic acid sodium salt
31121-93-4
5264-06-2
AC1NSQTG
AC1Q1V4C
AK128321
AKOS015994627
Ambcb5264062
Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, sodium salt
Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, sodium salt (9CI)
BIM-0005680.P001
C13H17O2.Na
CB08098
CHEMBL1241153
CTK4J6221
D08059
DTXSID4040501
EINECS 250-477-6
Esprenit (TN)
HS-0087
Hydratropic acid, p-isobutyl-, sodium salt
Ibuprofen sodium anhydrous
Ibuprofen sodium salt
Ibuprofen, Sodium Salt
IBUPROFENSODIUMSALT
KS-00002WUJ
LS-76355
MFCD00133414
MolPort-000-563-213
OR011634
OR256383
p-Isobutylhydratropic acid sodium salt
PTTPUWGBPLLBKW-UHFFFAOYSA-M
SCHEMBL139269
SMSF0005424
Sodium 2-(4-isobutylphenyl)propanoate
Sodium 2-(4-isobutylphenyl)propionate
sodium 2-(4'-isobutylphenyl)propionate
sodium 2-[4-(2-methylpropyl)phenyl]propanoate
Sodium ibuprofen
sodium ibuprofen salt
SODIUM P-ISOBUTYLHYDRATROPATE
W-110791

US Patents and Regulatory Information for IBUPROFEN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Cons Hlthcare ADVIL ibuprofen sodium TABLET;ORAL 201803-001 Jun 12, 2012 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Perrigo R And D IBUPROFEN SODIUM ibuprofen sodium TABLET;ORAL 206581-001 Aug 3, 2015 OTC No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Express Scripts
Johnson and Johnson
McKinsey
Cantor Fitzgerald
Fuji
Federal Trade Commission
Mallinckrodt
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.